Filing Details
- Accession Number:
- 0000899243-22-014804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-14 16:35:05
- Reporting Period:
- 2022-04-12
- Accepted Time:
- 2022-04-14 16:35:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1334365 | Yuchun Lee | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-04-12 | 2,000 | $81.54 | 3,875 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-04-12 | 200 | $279.22 | 3,675 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-12 | 1,182 | $280.61 | 2,493 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-12 | 318 | $281.70 | 2,175 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-12 | 300 | $283.15 | 1,875 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-04-13 | 2,000 | $81.54 | 3,875 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-04-13 | 18 | $281.49 | 3,857 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-13 | 300 | $283.73 | 3,557 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-13 | 228 | $284.90 | 3,329 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-13 | 300 | $286.24 | 3,029 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-13 | 200 | $287.42 | 2,829 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-13 | 400 | $288.55 | 2,429 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-13 | 200 | $290.17 | 2,229 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-13 | 354 | $291.12 | 1,875 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-04-12 | 2,000 | $0.00 | 2,000 | $81.54 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-04-13 | 2,000 | $0.00 | 2,000 | $81.54 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,000 | 2023-05-31 | No | 4 | M | Direct | |
4,000 | 2023-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
- Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $279.22 (range $279.14 to $279.30).
- Open market sales reported on this line occurred at a weighted average price of $280.61 (range $280.24 to $281.19).
- Open market sales reported on this line occurred at a weighted average price of $281.70 (range $281.45 to $281.98).
- Open market sales reported on this line occurred at a weighted average price of $283.15 (range $282.73 to $283.57).
- Open market sales reported on this line occurred at a weighted average price of $283.73 (range $283.30 to $284.10).
- Open market sales reported on this line occurred at a weighted average price of $284.90 (range $284.66 to $284.95).
- Open market sales reported on this line occurred at a weighted average price of $286.24 (range $285.99 to $286.60).
- Open market sales reported on this line occurred at a weighted average price of $287.42 (range $287.02 to $287.83).
- Open market sales reported on this line occurred at a weighted average price of $288.55 (range $288.23 to $289.11).
- Open market sales reported on this line occurred at a weighted average price of $290.17 (range $289.72 to $290.62).
- Open market sales reported on this line occurred at a weighted average price of $291.12 (range $290.80 to $291.42).
- Fully vested.